NPLATE (romiplostim)
THROMBOPOIETIC GROWTH FACTORS · SEVERE THROMBOCYTOPENIA IN REFRACTORY CHRONIC IMMUNE THROMBOCYTOPENIA PURPURA ·+1
AMGEN
Drug class
Thrombopoietic Growth Factors
Thrombopoietic growth factors are a class of hematopoietic agents—including recombinant cytokines such as interleukin-11 (oprelvekin) and thrombopoietin receptor agonists—that promote megakaryocytopoiesis and accelerate platelet production. Read more about Thrombopoietic Growth Factors
23 drugs in this class 16 manufacturers
Drugs in Thrombopoietic Growth Factors
PROMACTA (eltrombopag olamine)
THROMBOPOIETIC GROWTH FACTORS · APLASTIC ANEMIA ·+2
Novartis Pharmaceuticals
PROMACTA (eltrombopag olamine)
THROMBOPOIETIC GROWTH FACTORS · APLASTIC ANEMIA ·+2
Novartis Pharmaceuticals
DOPTELET (avatrombopag maleate)
THROMBOPOIETIC GROWTH FACTORS · SEVERE THROMBOCYTOPENIA IN REFRACTORY CHRONIC IMMUNE THROMBOCYTOPENIA PURPURA ·+1
AKARX, INC.
DOPTELET (avatrombopag maleate)
THROMBOPOIETIC GROWTH FACTORS · SEVERE THROMBOCYTOPENIA IN REFRACTORY CHRONIC IMMUNE THROMBOCYTOPENIA PURPURA ·+1
AKARX, INC.
DOPTELET (30 TAB PACK) (avatrombopag maleate)
THROMBOPOIETIC GROWTH FACTORS · SEVERE THROMBOCYTOPENIA IN REFRACTORY CHRONIC IMMUNE THROMBOCYTOPENIA PURPURA ·+1
AKARX, INC.
DOPTELET (10 TAB PACK) (avatrombopag maleate)
THROMBOPOIETIC GROWTH FACTORS · SEVERE THROMBOCYTOPENIA IN REFRACTORY CHRONIC IMMUNE THROMBOCYTOPENIA PURPURA ·+1
AKARX, INC.
DOPTELET (15 TAB PACK) (avatrombopag maleate)
THROMBOPOIETIC GROWTH FACTORS · SEVERE THROMBOCYTOPENIA IN REFRACTORY CHRONIC IMMUNE THROMBOCYTOPENIA PURPURA ·+1
AKARX, INC.
ALVAIZ (eltrombopag choline)
THROMBOPOIETIC GROWTH FACTORS · APLASTIC ANEMIA ·+2
TEVA PHARM
Filter & compare in the drug finder →
Opens the drug finder with Thrombopoietic Growth Factors preselected. Add indication or manufacturer filters there.
Thrombopoietic growth factors are a class of hematopoietic agents—including recombinant cytokines such as interleukin-11 (oprelvekin) and thrombopoietin receptor agonists—that promote megakaryocytopoiesis and accelerate platelet production.
By directly activating cell-surface receptors on hematopoietic stem cells and megakaryocyte progenitors, these agents stimulate progenitor proliferation and maturation into platelets to elevate peripheral platelet counts.
Therapeutically, they are utilized to manage or prevent clinically significant thrombocytopenia, most notably chemotherapy-induced thrombocytopenia in oncology, chronic immune thrombocytopenia, severe aplastic anemia, and thrombocytopenia associated with chronic liver disease undergoing planned procedures.
-
fda.gov
Thrombopoietic growth factors are a class of hematopoietic agents—including recombinant cytokines such as interleukin-11 (oprelvekin) and thrombopoietin receptor agonists—that promote megakaryocytopoiesis and accelerate platelet production By directly activating cell-surface receptors on hematopoietic stem cells and megakaryocyte progenitors, these agents stimulate progenitor proliferation and maturation into platelets to elevate peripheral platelet counts
-
nih.gov
Thrombopoietic growth factors are a class of hematopoietic agents—including recombinant cytokines such as interleukin-11 (oprelvekin) and thrombopoietin receptor agonists—that promote megakaryocytopoiesis and accelerate platelet production Therapeutically, they are utilized to manage or prevent clinically significant thrombocytopenia, most notably chemotherapy-induced thrombocytopenia in oncology
-
fda.gov
Therapeutically, they are utilized to manage or prevent clinically significant thrombocytopenia, most notably chemotherapy-induced thrombocytopenia in oncology
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.